Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Immune Thrombocytopenic Purpura
NCT00005652Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Dec 2000
- Primary completion
- Aug 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in immune thrombocytopenic purpura (ITP), sponsored by University of Alabama at Birmingham. Started Dec 2000; status: completed.
02
Drugs
rituximab
03
Conditions
immune thrombocytopenic purpura (ITP)
Beyond the preview
Go deeper on NCT00005652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005652.